Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma

Name: Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

esophageal squamous cell carcinoma by ajcc v8 stage, unresectable

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 366584
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.